Literature DB >> 27035784

Aerosolized Antibiotics for Patients with Bronchiectasis.

Tejaswi R Nadig1,2, Patrick A Flume1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27035784     DOI: 10.1164/rccm.201507-1449LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  6 in total

Review 1.  Medical management of bronchiectasis.

Authors:  Anne E O'Donnell
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 2.  Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Authors:  Patrick A Flume; James D Chalmers; Kenneth N Olivier
Journal:  Lancet       Date:  2018-09-08       Impact factor: 79.321

3.  Brazilian consensus on non-cystic fibrosis bronchiectasis.

Authors:  Mônica Corso Pereira; Rodrigo Abensur Athanazio; Paulo de Tarso Roth Dalcin; Mara Rúbia Fernandes de Figueiredo; Mauro Gomes; Clarice Guimarães de Freitas; Fernando Ludgren; Ilma Aparecida Paschoal; Samia Zahi Rached; Rosemeri Maurici
Journal:  J Bras Pneumol       Date:  2019-08-12       Impact factor: 2.624

4.  Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis.

Authors:  Marina Blanco-Aparicio; Jesús Luis Saleta Canosa; Paz Valiño López; María Teresa Martín Egaña; Iria Vidal García; Carmen Montero Martínez
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

Review 5.  The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.

Authors:  Rajiv Dhand
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-10-27       Impact factor: 2.849

6.  Rescue therapy within the UK Cystic Fibrosis Registry: An exploration of predictors of intravenous antibiotic use amongst adults with CF.

Authors:  Zhe Hui Hoo; Martin J Wildman; Rachael Curley; Stephen J Walters; Michael J Campbell
Journal:  Respirology       Date:  2017-09-14       Impact factor: 6.424

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.